Jefferies Financial Group Begins Coverage on Akero Therapeutics (NASDAQ:AKRO)

Share on StockTwits

Jefferies Financial Group started coverage on shares of Akero Therapeutics (NASDAQ:AKRO) in a report released on Monday, BenzingaRatingsTable reports. The brokerage issued a buy rating and a $28.00 price objective on the stock.

Other equities research analysts have also recently issued research reports about the stock. JPMorgan Chase & Co. reaffirmed a sell rating and set a $18.00 price objective on shares of ABB in a research report on Monday. Roth Capital reaffirmed a buy rating on shares of Coeur Mining in a research report on Monday.

AKRO opened at $21.55 on Monday. Akero Therapeutics has a twelve month low of $16.06 and a twelve month high of $21.94.

In related news, Director Seth Loring Harrison bought 900,000 shares of the company’s stock in a transaction dated Monday, June 24th. The stock was purchased at an average price of $16.00 per share, with a total value of $14,400,000.00. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, major shareholder Global Strategic Fund I. Venbio bought 250,000 shares of the company’s stock in a transaction dated Monday, June 24th. The stock was bought at an average cost of $16.00 per share, with a total value of $4,000,000.00. The disclosure for this purchase can be found here.

Akero Therapeutics Company Profile

Akero Therapeutics, Inc, a clinical-stage biotechnology company, engages in the development and commercialization of transformative treatments for serious metabolic diseases with high unmet medical need. Its lead product candidate is AKR-001, which completed Phase Ib clinical trial for the treatment of non-alcoholic steatohepatitis disease.

See Also: How is a Moving Average Calculated?

Receive News & Ratings for Akero Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akero Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

W Green Pay   Trading 8% Lower  Over Last Week
W Green Pay Trading 8% Lower Over Last Week
Brokerages Anticipate American Software, Inc.  to Announce $0.07 Earnings Per Share
Brokerages Anticipate American Software, Inc. to Announce $0.07 Earnings Per Share
MMOCoin   Trading 34.6% Lower  Over Last 7 Days
MMOCoin Trading 34.6% Lower Over Last 7 Days
Ambrosus Tops 24 Hour Trading Volume of $73,008.00
Ambrosus Tops 24 Hour Trading Volume of $73,008.00
Gems   Price Hits $0.0006 on Major Exchanges
Gems Price Hits $0.0006 on Major Exchanges
Air Transport Services Group Inc.  Expected to Announce Quarterly Sales of $327.28 Million
Air Transport Services Group Inc. Expected to Announce Quarterly Sales of $327.28 Million


 
© 2006-2019 Zolmax.